And so the roller-coaster markets continue. Fortunately, I know how to ride roller-coasters with the best of them. I have plenty of experience to work with. That's why I’m digging into my past life to bring two companies to your attention today.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the specialty retail industry, including Leslie's (NASDAQ:LESL) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the specialty retail industry, including National Vision (NASDAQ:EYE) and its peers.
The S&P 500 is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
SenesTech, an under-the-radar biotech company with a focus on solving the global pest population problem through, humane fertility control measures, seems attractively valued.
With no direct competition in the fertility control space and growing demand for non-lethal rodent management, could SNES be the next big winner? Find out in this deep-dive conversation with CEO Joel Fruendt.
February's Consumer Price Index (CPI) rose 2.8% year-over-year, with core CPI at 3.1%. While both headline and core indices saw a 0.2% month-over-month increase, they underperformed expectations. Price changes were observed across categories, including deflation in TVs, and price increases in Appliances and Pet Food, signaling a gradual easing of inflationary pressures, according to J.P. Morgan analyst Christopher Horvers.
Splits are generally covered in positivity, as they allow a greater portion of investors to get in. While it’s a positive development, it’s critical to realize that splits aren’t an explicit buy signal.
Tractor Supply has been treading water for the past six months, recording a small return of 1.2% while holding steady at $54.78. The stock also fell short of the S&P 500’s 7% gain during that period.
SenesTech is a small company with an innovative way for rodent control using induced infertility. They have rapidly expanded with pilot programs in major US cities and also globally in New Zealand and Australia.
